VMP 42375511000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Irbesartan 300mg tablets
BNF code 0205052I0AAACAC
Virtual Therapeutic Moiety Irbesartan
Date identifier became valid 27 Oct 2023
Previous product identifier 318970006
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Irbesartan
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 300.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Aprovel 300mg tablets (CST Pharma Ltd)
Aprovel 300mg tablets (Sanofi)
Irbesartan 300mg tablets (A A H Pharmaceuticals Ltd)
Irbesartan 300mg tablets (Accord-UK Ltd)
Irbesartan 300mg tablets (Alliance Healthcare (Distribution) Ltd)
Irbesartan 300mg tablets (Amarox Ltd)
Irbesartan 300mg tablets (Bristol Laboratories Ltd)
Irbesartan 300mg tablets (Brown & Burk UK Ltd)
Irbesartan 300mg tablets (Crescent Pharma Ltd)
Irbesartan 300mg tablets (Krka UK Ltd)
Irbesartan 300mg tablets (Macleods Pharma UK Ltd)
Irbesartan 300mg tablets (Medihealth (Northern) Ltd)
Irbesartan 300mg tablets (Milpharm Ltd)
Irbesartan 300mg tablets (Sigma Pharmaceuticals Plc)
Irbesartan 300mg tablets (Sigma Pharmaceuticals Plc)
Irbesartan 300mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Irbesartan 300mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback